![The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41577-022-00809-x/MediaObjects/41577_2022_809_Fig1_HTML.png)
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology
![Is preexisting immunity to seasonal coronaviruses limited to cross- reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France - eBioMedicine Is preexisting immunity to seasonal coronaviruses limited to cross- reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France - eBioMedicine](https://www.thelancet.com/cms/attachment/86769381-94ba-420c-91c9-6c2bb6aa8800/gr1_lrg.jpg)
Is preexisting immunity to seasonal coronaviruses limited to cross- reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France - eBioMedicine
![Cells | Free Full-Text | Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens Cells | Free Full-Text | Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens](https://pub.mdpi-res.com/cells/cells-08-00507/article_deploy/html/images/cells-08-00507-ag.png?1571589884)
Cells | Free Full-Text | Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens
![Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination | Science Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination | Science](https://www.science.org/cms/10.1126/science.abh1823/asset/d4a1f17b-9af5-451f-a00e-5bbd8af0c6b1/assets/images/large/science.abh1823-f1.jpg)
Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination | Science
![Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection | Science Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection | Science](https://www.science.org/cms/10.1126/science.aaf8505/asset/9f11bfb5-c695-48e1-82be-141a8bb68957/assets/graphic/353_823_f1.jpeg)
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection | Science
![Cross-reactivity in antibody microarrays and multiplexed sandwich assays: shedding light on the dark side of multiplexing - ScienceDirect Cross-reactivity in antibody microarrays and multiplexed sandwich assays: shedding light on the dark side of multiplexing - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1367593113002317-gr1.jpg)
Cross-reactivity in antibody microarrays and multiplexed sandwich assays: shedding light on the dark side of multiplexing - ScienceDirect
![Use of Tissue Cross-reactivity Studies in the Development of Antibody-based Biopharmaceuticals: History, Experience, Methodology, and Future Directions - Michael W. Leach, Wendy G. Halpern, Carol W. Johnson, Jennifer L. Rojko, Tim K. Use of Tissue Cross-reactivity Studies in the Development of Antibody-based Biopharmaceuticals: History, Experience, Methodology, and Future Directions - Michael W. Leach, Wendy G. Halpern, Carol W. Johnson, Jennifer L. Rojko, Tim K.](https://journals.sagepub.com/cms/10.1177/0192623310382559/asset/images/large/10.1177_0192623310382559-fig2.jpeg)
Use of Tissue Cross-reactivity Studies in the Development of Antibody-based Biopharmaceuticals: History, Experience, Methodology, and Future Directions - Michael W. Leach, Wendy G. Halpern, Carol W. Johnson, Jennifer L. Rojko, Tim K.
![JCI Insight - Cross-reactivity of SARS-CoV-2– and influenza A–specific T cells in individuals exposed to SARS-CoV-2 JCI Insight - Cross-reactivity of SARS-CoV-2– and influenza A–specific T cells in individuals exposed to SARS-CoV-2](https://df6sxcketz7bb.cloudfront.net/manuscripts/158000/158308/medium/jci.insight.158308.ga.jpg)
JCI Insight - Cross-reactivity of SARS-CoV-2– and influenza A–specific T cells in individuals exposed to SARS-CoV-2
![Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/03/18/2020.03.17.995738/F1.large.jpg)
Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv
![Cross-Reactivity, Epitope Mapping, and Potency of Monoclonal Antibodies to Class 5 Fimbrial Tip Adhesins of Enterotoxigenic Escherichia coli | Infection and Immunity Cross-Reactivity, Epitope Mapping, and Potency of Monoclonal Antibodies to Class 5 Fimbrial Tip Adhesins of Enterotoxigenic Escherichia coli | Infection and Immunity](https://journals.asm.org/cms/10.1128/iai.00246-20/asset/03bd904e-5f4f-4cb2-b07a-4997d72a820a/assets/graphic/iai.00246-20-f0002.jpeg)
Cross-Reactivity, Epitope Mapping, and Potency of Monoclonal Antibodies to Class 5 Fimbrial Tip Adhesins of Enterotoxigenic Escherichia coli | Infection and Immunity
![Frontiers | Cross-Reactivity of TCR Repertoire: Current Concepts, Challenges, and Implication for Allotransplantation Frontiers | Cross-Reactivity of TCR Repertoire: Current Concepts, Challenges, and Implication for Allotransplantation](https://www.frontiersin.org/files/Articles/181111/fimmu-07-00089-HTML/image_m/fimmu-07-00089-g001.jpg)